Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) Gross Profit (2021 - 2025)

Historic Gross Profit for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $266.0 million.

  • Rxo's Gross Profit fell 1419.35% to $266.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 1482.23%. This contributed to the annual value of $1.1 billion for FY2025, which is 1482.23% up from last year.
  • Rxo's Gross Profit amounted to $266.0 million in Q4 2025, which was down 1419.35% from $284.0 million recorded in Q3 2025.
  • In the past 5 years, Rxo's Gross Profit registered a high of $322.0 million during Q2 2022, and its lowest value of $214.0 million during Q1 2024.
  • Moreover, its 5-year median value for Gross Profit was $271.0 million (2021), whereas its average is $264.7 million.
  • Per our database at Business Quant, Rxo's Gross Profit crashed by 2546.58% in 2023 and then soared by 3191.49% in 2024.
  • Rxo's Gross Profit (Quarter) stood at $276.0 million in 2021, then increased by 0.72% to $278.0 million in 2022, then decreased by 15.47% to $235.0 million in 2023, then skyrocketed by 31.91% to $310.0 million in 2024, then decreased by 14.19% to $266.0 million in 2025.
  • Its last three reported values are $266.0 million in Q4 2025, $284.0 million for Q3 2025, and $301.0 million during Q2 2025.